Feature
A New Type of Immunotherapy: MSK’s Christopher Klebanoff Is Fighting Cancer Cells From the Inside Out With T Cell Receptor (TCR) Therapy
Learn how MSK physician-scientist Christopher Klebanoff is working to bring immunotherapy to more patients, especially those with solid tumors.
In the Lab
CAR T Cells Get an Invisibility Cloak
Research is focusing on ways to help cancer-fighting immune cells stick around longer, boosting their effectiveness.
